What is mecta?
mecta, operating within the medical technology sector, specializes in the development and provision of electroconvulsive therapy (ECT) devices and associated products. The company primarily serves licensed health providers and hospitals, ensuring its offerings are exclusively distributed to medical professionals. Beyond device sales, mecta contributes to the field through ECT training programs, fellowships, and educational resources for clinicians and patient families. Their business model strictly adheres to professional distribution channels, avoiding direct patient engagement or medical advice.
How much funding has mecta raised?
mecta has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in mecta
PPP
Public-Private Partnership
What's next for mecta?
The substantial capital raised, particularly the recent large-scale late-stage funding, positions mecta for significant growth and strategic initiatives. This investment is likely to fuel advancements in their ECT device technology, expand their market reach to more healthcare institutions, and potentially enhance their training and support services. The company's focus on professional markets suggests a strategy aimed at solidifying its role as a key supplier and educator in the specialized field of ECT.
See full mecta company page
